Literature DB >> 10527737

Microimaging at 14 tesla using GESEPI for removal of magnetic susceptibility artifacts in T(2)(*)-weighted image contrast.

Q X Yang1, M B Smith, R W Briggs, R E Rycyna.   

Abstract

In magnetic resonance imaging (MRI), T(2)(*)-weighted contrast is significantly enhanced by extremely high magnetic field strength, offering broad potential applications. However, the T(2)(*)-weighted image contrast distortion and signal loss artifact arising from discontinuities of magnetic susceptibility within and around the sample are also increased, limiting utilization of high field systems for T(2)(*)-weighted contrast applications. Due to the B(0) dependence of the contrast distortions and signal losses, and the heterogeneity of magnetic susceptibility in biological samples, magnetic susceptibility artifacts worsen dramatically for in vivo microimaging at higher fields. Practical applications of T(2)(*)-sensitive techniques enhanced by higher magnetic fields are therefore challenged. This report shows that magnetic susceptibility artifacts dominate T(2)(*)-weighted image contrast at 14 T, and demonstrates that the GESEPI (gradient echo slice excitation profile imaging) technique effectively reduces or eliminates these artifacts at long TE in the highest field (14 T) currently available for (1)H imaging. Copyright 1999 Academic Press.

Mesh:

Year:  1999        PMID: 10527737     DOI: 10.1006/jmre.1999.1900

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  2 in total

1.  Behavior of metal implants used in ENT surgery in 7 Tesla magnetic resonance imaging.

Authors:  Ariane Thelen; Hans-Christian Bauknecht; Patrick Asbach; Thomas Schrom
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-12       Impact factor: 2.503

2.  Common-mode differential-mode (CMDM) method for double-nuclear MR signal excitation and reception at ultrahigh fields.

Authors:  Yong Pang; Xiaoliang Zhang; Zhentian Xie; Chunsheng Wang; Daniel B Vigneron
Journal:  IEEE Trans Med Imaging       Date:  2011-06-20       Impact factor: 10.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.